10-K Decoder · All companies

Royalty Pharma plc

RPRX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$2.38B$2.26B+5.1%
Operating income$1.56B$1.29B+20.7%
Net income$771M$859M−10.2%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$690M$609M+13.3%
Operating income$411M$427M−3.8%
Net income$145M$284M−49.1%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Royalty Pharma's revenue in FY2025?
$2.38B in FY2025 (Fiscal year ended Dec 31, 2025), +5.1% vs $2.26B a year earlier, per its 10-K filed Feb 2026.
Was Royalty Pharma profitable in FY2025?
Yes: net income was $771M and operating income $1.56B in FY2025.
What was Royalty Pharma's revenue in Q3 2026?
$690M (+13.3% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.